ELY BENAIM

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Opus Genetics, Inc.

Filing Date Source Excerpt
2018-07-23 Ely Benaim Includes Dr. Benaim’s options to purchase 169,456 shares of Common Stock that are currently exercisable or exercisable within 60 days of July 10, 2018.
2019-02-14 Ely Benaim - Director

Data sourced from SEC filings. Last updated: 2026-02-03